Adverum Capital Lease Obligations from 2010 to 2024
| ADVM Stock | USD 7.58 0.06 0.80% |
Capital Lease Obligations | First Reported 2019-03-31 | Previous Quarter 75 M | Current Value 74.5 M | Quarterly Volatility 37.6 M |
Check Adverum Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adverum Biotechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.9 M, Interest Expense of 3.2 M or Selling General Administrative of 31.8 M, as well as many indicators such as Price To Sales Ratio of 23.04, Dividend Yield of 0.0 or PTB Ratio of 0.96. Adverum financial statements analysis is a perfect complement when working with Adverum Biotechnologies Valuation or Volatility modules.
Adverum | Capital Lease Obligations |
Latest Adverum Biotechnologies' Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Adverum Biotechnologies over the last few years. Adverum Biotechnologies capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Adverum Biotechnologies asset purchases. For example, Adverum Biotechnologies can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Adverum Biotechnologies control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Adverum Biotechnologies' Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adverum Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Adverum Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 47,635,557 | |
| Geometric Mean | 42,154,620 | |
| Coefficient Of Variation | 58.32 | |
| Mean Deviation | 22,773,751 | |
| Median | 32,248,000 | |
| Standard Deviation | 27,780,065 | |
| Sample Variance | 771.7T | |
| Range | 76.1M | |
| R-Value | 0.70 | |
| Mean Square Error | 423.7T | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | 4,348,998 | |
| Total Sum of Squares | 10804.2T |
Adverum Capital Lease Obligations History
About Adverum Biotechnologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Adverum Biotechnologies income statement, its balance sheet, and the statement of cash flows. Adverum Biotechnologies investors use historical funamental indicators, such as Adverum Biotechnologies's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although Adverum Biotechnologies investors may use each financial statement separately, they are all related. The changes in Adverum Biotechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Adverum Biotechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Adverum Biotechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Adverum Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 75 M | 76.5 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Adverum Biotechnologies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Adverum Stock
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:Check out the analysis of Adverum Biotechnologies Correlation against competitors. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.20) | Quarterly Revenue Growth (0.70) | Return On Assets (0.28) | Return On Equity (0.66) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.